CX 3CR1 + CD115 + CD135 + common macrophage/DC precursors and the role of CX 3CR1 in their response to inflammation

Journal of Experimental Medicine

Volumn 206, Issue 3, 2009, Pages 595-606

  Auffray, Cedric ^a   Fogg, Darin K ^a   Narni Mancinelli, Emilie ^a   Senechal, Brigitte ^a   Trouillet, Celine ^a,b   Saederup, Noah ^c   Leemput, Julia ^d   Bigot, Karine ^d   Campisi, Laura ^a   Abitbol, Marc ^d   Molina, Thierry ^a   Charo, Israel ^c   Hume, David A ^e   Cumano, Ana ^f   Lauvau, Gregoire ^a   Geissmann, Frederic ^a,b  

^a INSERM   (France)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD115 ANTIGEN; CD135 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; INDUCIBLE NITRIC OXIDE SYNTHASE; LYMPHOCYTE ANTIGEN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR; COLONY STIMULATING FACTOR RECEPTOR; CX3CR1 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; IN VIVO STUDY; LISTERIOSIS; MACROPHAGE; MOUSE; MYELOID PROGENITOR CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; CELL MOTION; CYTOLOGY; ENZYMOLOGY; IMMUNOLOGY; INFLAMMATION; LISTERIA MONOCYTOGENES; METABOLISM; MICROBIOLOGY; MONOCYTE; PHENOTYPE; SPLEEN; STEM CELL;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DENDRITIC CELLS; FMS-LIKE TYROSINE KINASE 3; INFLAMMATION; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MACROPHAGES; MICE; MONOCYTES; NITRIC OXIDE SYNTHASE TYPE II; PHENOTYPE; REACTIVE OXYGEN SPECIES; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTORS, CHEMOKINE; SPLEEN; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 63449110370     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20081385     Document Type: Article

References (50)

1. Sasmono, R.T., D. Oceandy, J.W. Pollard, W. Tong, P. Pavli, B.J. Wainwright, M.C. Ostrowski, S.R. Himes, and D.A. Hume. 2003. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood. 101:1155-1163.
2. MacDonald, K.P., V. Rowe, H.M. Bofinger, R. Thomas, T. Sasmono, D.A. Hume, and G.R. Hill. 2005. The colony-stimulating factor 1 receptor is expressed on dendritic cells during differentiation and regulates their expansion. J. Immunol. 175:1399-1405.
3. Banchereau, J., and R.M. Steinman. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
4. Gordon, S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell. 111:927-930.
5. Taylor, P.R., and S. Gordon. 2003. Monocyte heterogeneity and innate immunity. Immunity. 19:2-4.
6. Shortman, K., and Y.J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-161.
7. Lin, H., E. Lee, K. Hestir, C. Leo, M. Huang, E. Bosch, R. Halenbeck, G. Wu, A. Zhou, D. Behrens, et al. 2008. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science. 320:807-811.
8. Dai, X.M., G.R. Ryan, A.J. Hapel, M.G. Dominguez, R.G. Russell, S. Kapp, V. Sylvestre, and E.R. Stanley. 2002. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood. 99:111-120.
9. Waskow, C., K. Liu, G. Darrasse-Jeze, P. Guermonprez, F. Ginhoux, M. Merad, T. Shengelia, K. Yao, and M. Nussenzweig. 2008. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 9:676-683.
10. Kabashima, K., T.A. Banks, K.M. Ansel, T.T. Lu, C.F. Ware, and J.G. Cyster. 2005. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity. 22:439-450.
11. Maraskovsky, E., K. Brasel, M. Teepe, E.R. Roux, S.D. Lyman, K. Shortman, and H.J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953-1962.
12. McKenna, H.J. 2000. Mice lacking Flt3 ligand have deficient hematopoi-esis affecting hematopoietic progenitor cells, dendritic cells, and naturalkiller cells. Blood. 95:3489-3497.
13. D'Amico, A., and L. Wu. 2003. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J. Exp. Med. 198:293-303.
14. Brasel, K., H.J. McKenna, P.J. Morrissey, K. Charrier, A.E. Morris, C.C. Lee, D.E. Williams, and S.D. Lyman. 1996. Hematologic effects of flt3 ligand in vivo in mice. Blood. 88:2004-2012.
15. Wiktor-Jedrzejczak, W., E. Urbanowska, and M. Szperl. 1994. Granulocyte-macrophage colony-stimulating factor corrects macrophage deficiencies, but not osteopetrosis, in the colony-stimulating factor-1-deficient op/op mouse. Endocrinology. 134:1932-1935.
16. Dieu-Nosjean, M.C., A. Vicari, S. Lebecque, and C. Caux. 1999. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J. Leukoc. Biol. 66:252-262.
17. Kurihara, T., G. Warr, J. Loy, and R. Bravo. 1997. Defects in macro-phage recruitment and host defense in mice lacking the CCR2 chemo-kine receptor. J. Exp. Med. 186:1757-1762.
18. Kennedy, D.W., and J.L. Abkowitz. 1998. Mature monocytic cells enter tissues and engraft. Proc. Natl. Acad. Sci. USA. 95:14944-14949.
19. Inaba, K., M. Inaba, M. Deguchi, K. Hagi, R. Yasumizu, S. Ikehara, S. Muramatsu, and R.M. Steinman. 1993. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc. Natl. Acad. Sci. USA. 90:3038-3042.
20. Manz, M.G., D. Traver, K. Akashi, M. Merad, T. Miyamoto, E.G. Engleman, and I.L. Weissman. 2001. Dendritic cell development from common myeloid progenitors. Ann. N. Y. Acad. Sci. 938:167-173.
21. Akashi, K., D. Traver, T. Miyamoto, and I.L. Weissman. 2000. A clo-nogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 404:193-197.
22. Fogg, D.K., C. Sibon, C. Miled, S. Jung, P. Aucouturier, D.R. Littman, A. Cumano, and F. Geissmann. 2006. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science. 311:83-87.
23. Varol, C., L. Landsman, D.K. Fogg, L. Greenshtein, B. Gildor, R. Margalit, V. Kalchenko, F. Geissmann, and S. J ung. 2007. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 204:171-180.
24. Naik, S.H., P. Sathe, H.Y. Park, D. Metcalf, A.I. Proietto, A. Dakic, S. Carotta, M. O'Keeffe, M. Bahlo, A. Papenfuss, et al. 2007. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat. Immunol. 8:1217-1226.
25. Onai, N., A. Obata-Onai, M.A. Schmid, T. Ohteki, D. Jarrossay, and M.G. Manz. 2007. I dentification of clonogenic common Flt3(+)M-CSFR(+) plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat. Immunol. 8:1207-1216.
26. Jose, M.D., Y. Le Meur, R.C. Atkins, and S.J. Chadban. 2003. Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am. J. Transplant. 3:294-300.
27. Murayama, T., M. Yokode, H. Kataoka, T. Imabayashi, H. Yoshida, H. Sano, S. Nishikawa, S. Nishikawa, and T. Kita. 1999. Intraperitoneal administration of anti-c-fms monoclonal antibody prevents initial events of atherogenesis but does not reduce the size of advanced lesions in apolipoprotein E-deficient mice. Circulation. 99:1740-1746.
28. Sudo, T., S. Nishikawa, M. Ogawa, H. Kataoka, N. Ohno, A. Izawa, S. Hayashi, and S. Nishikawa. 1995. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene. 11:2469-2476.
29. Geissmann, F., S. Jung, and D.R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 19:71-82.
30. Miyamoto, A., T. Kunisada, H. Yamazaki, K. Miyake, S.I. Nishikawa, T. Sudo, L.D. Shultz, and S.I. Hayashi. 1998. Establishment and characterization of pro-B cell lines from motheaten mutant mouse defective in SHP-1 protein tyrosine phosphatase. Immunol. Lett. 63:75-82.
31. Kitaura, H., P. Zhou, H.J. Kim, D.V. Novack, F.P. Ross, and S.L. Teitelbaum. 2005. M-CSF mediates TNF-induced inflammatory oste-olysis. J. Clin. Invest. 115:3418-3427.
32. Nahrendorf, M., F.K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, J.L. Figueiredo, P. Libby, R. Weissleder, and M.J. Pittet. 2007. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204:3037-3047.
33. Imai, T., K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T.J. Schall, and O. Yoshie. 1997. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 91:521-530.
34. Jung, S., J. Aliberti, P. Graemmel, M.J. Sunshine, G.W. Kreutzberg, A. Sher, and D.R. Littman. 2000. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20:4106-4114.
35. Cook, D.N., S.C. Chen, L.M. Sullivan, D.J. Manfra, M.T. Wiekowski, D.M. Prosser, G. Vassileva, and S.A. Lira. 2001. Generation and analysis of mice lacking the chemokine fractalkine. Mol. Cell. Biol. 21:3159-3165.
36. -/- mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 111:333-340.
37. Kanazawa, N., T. Nakamura, K. Tashiro, M. Muramatsu, K. Morita, K. Yoneda, K. I naba, S. I mamura, and T. Honjo. 1999. Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells. Eur. J. Immunol. 29:1925-1932.
38. Ancuta, P., R. Rao, A. Moses, A. Mehle, S.K. Shaw, F.W. Luscinskas, and D. Gabuzda. 2003. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 197:1701-1707.
39. Haskell, C.A., M.D. Cleary, and I.F. Charo. 2000. Unique role of the chemokine domain of fractalkine in cell capture. Kinetics of receptor dissociation correlate with cell adhesion. J. Biol. Chem. 275:34183-34189.
40. Fong, A.M., L.A. Robinson, D.A. Steeber, T.F. Tedder, O. Yoshie, T. Imai, and D.D. Patel. 1998. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188:1413-1419.
41. Goda, S., T. Imai, O. Yoshie, O. Yoneda, H. Inoue, Y. Nagano, T. Okazaki, H. Imai, E.T. Bloom, N. Domae, and H. Umehara. 2000. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms. J. Immunol. 164:4313-4320.
42. Auffray, C., D. Fogg, M. Garfa, G. Elain, O. Join-Lambert, S. Kayal, S. Sarnacki, A. Cumano, G. Lauvau, and F. Geissmann. 2007. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science. 317:666-670.
43. Cardona, A.E., E.P. Pioro, M.E. Sasse, V. Kostenko, S.M. Cardona, I.M. Dijkstra, D. Huang, G. Kidd, S. Dombrowski, R. Dutta, et al. 2006. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9:917-924.
44. Serbina, N.V., W. Kuziel, R. Flavell, S. Akira, B. Rollins, and E.G. Pamer. 2003. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity. 19:891-901.
45. Serbina, N.V., and E.G. Pamer. 2006. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemo-kine receptor CCR2. Nat. Immunol. 7:311-317.
46. Serbina, N.V., T.P. Salazar-Mather, C.A. Biron, W.A. Kuziel, and E.G. Pamer. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 19:59-70.
47. + and CD103- pulmonary dendritic cell populations. J. Immunol. 180:3019-3027.
48. Brand, S., T. Sakaguchi, X. Gu, S.P. Colgan, and H.C. Reinecker. 2002. Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology. 122:166-177.
49. Shulby, S.A., N.G. Dolloff, M.E. Stearns, O. Meucci, and A. Fatatis. 2004. CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res. 64:4693-4698.
50. Tsou, C.L., W. Peters, Y. Si, S. Slaymaker, A.M. Aslanian, S.P. Weisberg, M. Mack, and I.F. Charo. 2007. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117:902-909.